These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31353677)

  • 1. Profiling the interaction of 1-phenylbenzimidazoles to cyclooxygenases.
    Gómez-Castro CZ; López-Martínez M; Hernández-Pineda J; Trujillo-Ferrara JG; Padilla-Martínez II
    J Mol Recognit; 2019 Nov; 32(11):e2801. PubMed ID: 31353677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modelling of the differential interaction between several non-steroidal anti-inflammatory drugs and human prostaglandin endoperoxide H synthase-2 (h-PGHS-2).
    Pouplana R; Lozano JJ; Ruiz J
    J Mol Graph Model; 2002 Jan; 20(4):329-43. PubMed ID: 11858641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of the dynamic mechanism of ligand binding to cyclooxygenase.
    Llorens O; Perez JJ; Palomer A; Mauleon D
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2779-84. PubMed ID: 10522690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site.
    Loll PJ; Picot D; Ekabo O; Garavito RM
    Biochemistry; 1996 Jun; 35(23):7330-40. PubMed ID: 8652509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential binding mode of diverse cyclooxygenase inhibitors.
    Llorens O; Perez JJ; Palomer A; Mauleon D
    J Mol Graph Model; 2002 Mar; 20(5):359-71. PubMed ID: 11885959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.
    Kurumbail RG; Stevens AM; Gierse JK; McDonald JJ; Stegeman RA; Pak JY; Gildehaus D; Miyashiro JM; Penning TD; Seibert K; Isakson PC; Stallings WC
    Nature; 1996 Dec 19-26; 384(6610):644-8. PubMed ID: 8967954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemometric rationalization of the structural and physicochemical basis for selective cyclooxygenase-2 inhibition: toward more specific ligands.
    Filipponi E; Cecchetti V; Tabarrini O; Bonelli D; Fravolini A
    J Comput Aided Mol Des; 2000 Mar; 14(3):277-91. PubMed ID: 10756482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structural and electronical factors that contribute affinity for the time-dependent inhibition of PGHS-1 by indomethacin, diclofenac and fenamates.
    Pouplana R; Pérez C; Sánchez J; Lozano JJ; Puig-Parellada P
    J Comput Aided Mol Des; 1999 May; 13(3):297-313. PubMed ID: 10216835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking studies on NSAID/COX-2 isozyme complexes using contact statistics analysis.
    Ermondi G; Caron G; Lawrence R; Longo D
    J Comput Aided Mol Des; 2004 Nov; 18(11):683-96. PubMed ID: 15865061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines.
    Mandal P; Kundu BK; Vyas K; Sabu V; Helen A; Dhankhar SS; Nagaraja CM; Bhattacherjee D; Bhabak KP; Mukhopadhyay S
    Dalton Trans; 2018 Jan; 47(2):517-527. PubMed ID: 29235601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models.
    Palomer A; Cabré F; Pascual J; Campos J; Trujillo MA; Entrena A; Gallo MA; García L; Mauleón D; Espinosa A
    J Med Chem; 2002 Mar; 45(7):1402-11. PubMed ID: 11906281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmethyl derivatives of indomethacin and sulindac as probes for cyclooxygenase-dependent biology.
    Felts AS; Ji C; Stafford JB; Crews BC; Kingsley PJ; Rouzer CA; Washington MK; Subbaramaiah K; Siegel BS; Young SM; Dannenberg AJ; Marnett LJ
    ACS Chem Biol; 2007 Jul; 2(7):479-83. PubMed ID: 17602619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective binding of indomethacin ethanolamide derivatives to cyclooxygenase-1.
    Moth CW; Prusakiewicz JJ; Marnett LJ; Lybrand TP
    J Med Chem; 2005 May; 48(10):3613-20. PubMed ID: 15887968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
    Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
    Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition.
    Limongelli V; Bonomi M; Marinelli L; Gervasio FL; Cavalli A; Novellino E; Parrinello M
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5411-6. PubMed ID: 20215464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors.
    Kalgutkar AS; Marnett AB; Crews BC; Remmel RP; Marnett LJ
    J Med Chem; 2000 Jul; 43(15):2860-70. PubMed ID: 10956194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without COX inhibitory activity.
    Arisawa M; Kasaya Y; Obata T; Sasaki T; Nakamura T; Araki T; Yamamoto K; Sasaki A; Yamano A; Ito M; Abe H; Ito Y; Shuto S
    J Med Chem; 2012 Sep; 55(18):8152-63. PubMed ID: 22916727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory mode of 1,5-diarylpyrazole derivatives against cyclooxygenase-2 and cyclooxygenase-1: molecular docking and 3D QSAR analyses.
    Liu H; Huang X; Shen J; Luo X; Li M; Xiong B; Chen G; Shen J; Yang Y; Jiang H; Chen K
    J Med Chem; 2002 Oct; 45(22):4816-27. PubMed ID: 12383007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,5-Diarylpyrrole-3-acetic acids and esters as novel classes of potent and highly selective cyclooxygenase-2 inhibitors.
    Biava M; Porretta GC; Cappelli A; Vomero S; Manetti F; Botta M; Sautebin L; Rossi A; Makovec F; Anzini M
    J Med Chem; 2005 May; 48(9):3428-32. PubMed ID: 15857149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.